Timing of Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage for Acute Cholecystitis: a Nationwide Inpatient Database Study
Overview
Affiliations
Background: Optimal interval from percutaneous transhepatic gallbladder drainage (PTGBD) to cholecystectomy for acute cholecystitis remains unclear.
Methods: We analyzed patients undergoing cholecystectomy following PTGBD for acute cholecystitis, using a national database. We performed restricted cubic spline (RCS) analyses to investigate the association of interval from PTGBD to cholecystectomy with outcomes (mortality/morbidity, blood transfusion, duration of anesthesia, and postoperative hospital stay).
Results: Among 9,256 patients, RCS analyses showed reverse J-shaped associations of the interval with mortality/morbidity and blood transfusion, and J-shaped associations of the interval with both duration of anesthesia and postoperative hospital stay. Each interval was compared with the bottom of the spline curve. Patients with intervals ≤6 days or ≥27 days had higher mortality/morbidity than those with a 10-day interval. Patients with intervals ≤8 days had higher proportions of blood transfusion than those with a 10-day interval. Patients with intervals ≥17 days had longer duration of anesthesia than those with a 5-day interval. Postoperative hospital stay was longer among those with intervals ≤10 days or ≥19 days than those with a 15-day interval.
Conclusions: Based on the mortality/morbidity data, the optimum time to perform cholecystectomy is between 7 and 26 days after PTGBD.
Kujirai D, Isobe Y, Suzumura H, Matsumoto K, Sasakura Y, Terauchi T BMC Surg. 2024; 24(1):389.
PMID: 39702194 PMC: 11656828. DOI: 10.1186/s12893-024-02688-6.
Gao W, Zheng J, Bai J, Han Z World J Gastrointest Surg. 2024; 16(11):3445-3452.
PMID: 39649200 PMC: 11622070. DOI: 10.4240/wjgs.v16.i11.3445.
Spaniolas K, Pryor A, Stefanidis D, Giannopoulos S, Miller P, Spencer A Surg Endosc. 2024; 38(10):6053-6059.
PMID: 39134720 DOI: 10.1007/s00464-024-11145-7.
Lyu Y, Wang B Surg Laparosc Endosc Percutan Tech. 2024; 34(5):479-484.
PMID: 39016308 PMC: 11446531. DOI: 10.1097/SLE.0000000000001304.
Lee O, Shin Y, Ryu Y, Yoon S, Kim H, Shin S Ann Surg Treat Res. 2023; 105(5):310-318.
PMID: 38023435 PMC: 10648612. DOI: 10.4174/astr.2023.105.5.310.